|
Novartis Announce Tasigna® Approved by FDA for Chronic Myeloid Leukemia (CML)
Nov 12, 2007 - 9:30 pm
(edited on Nov 12, 2007 09:38 pm)
1 Answers - 359 Views Posted by Mr. Aaron Poffenberger
On October 29th Novartis announced that "been approved in the US as a new anti-cancer therapy for certain patients with a life-threatening form of leukemia who are resistant or intolerant to prior treatment including Glivec® (imatinib)*, an established treatment standard and a leading Novartis medicine....
Showing entries 1 to 1 of 1
|
|
|
|
XXX
Discussion